Search - tctmd.com

Displaying 561 - 580 of 900

Sort: Relevancy | Date

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Rod H. Stables

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Gregg W. Stone

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Stefanie Schüpke

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Roxana Mehran

September 14, 2014

Presentation TCT 2014

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Presenter: Kishore J. Harjai, Michael S. Lee

September 14, 2014

Presentation TCT 2014

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Presenter: Paul A. Gurbel, Dmitriy N. Feldman

September 14, 2014

Presentation TCT 2014

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

Presenter: Roxana Mehran, Mohamed Sobhy

September 13, 2014

Presentation TCT 2014

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in Those Undergoing PCI

Presenter: Frederick Feit, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

Optimal Duration of DAPT After Intracoronary Stenting: Current Status

Presenter: Roxana Mehran

September 13, 2014

Presentation TCT 2014

Are GP IIb/IIIa Inhibitors Still Useful?

Presenter: Marco Valgimigli

September 13, 2014

Presentation

Aspirin Treatment and Outcomes After PCI

Presenter: Katharina Mayer

August 25, 2014

Presentation

Bivalirudin vs Heparin in Patients Planned for PCI

Presenter: Matthew A. Cavender

August 20, 2014

Presentation

Early High-Dose Rosuvastatin and Cardioprotection

Presenter: M. Leoncini

August 19, 2014

Presentation

Contemporary Patterns of Discharge Aspirin Dosing After Acute MI in the United States

Presenter: H.M. Hall

August 13, 2014

Presentation

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Presenter: Akshay Bagai

August 12, 2014

Presentation

Issues with DAPT: An Expert Case-Based Discussion

Presenter: Jonathan Halperin, Ajay Kirtane, Roxana Mehran

July 29, 2014

Presentation

Pharmacotherapy for Primary PCI - Late Breaking Trials: EUROMAX, HEAT-PPCI, BRIGHT, and BRAVE 4

Presenter: Gregg W. Stone

July 23, 2014

Presentation

Variability of Individual Platelet Reactivity Over Time in Patients Treated with Clopidogrel

Presenter: W. Hochholzer

July 21, 2014

Presentation

STREAM Substudy: Outcomes of Pharmacoinvasive Strategy for Successful vs Failed Fibrinolysis and Primary PCI in AMI

Presenter: R.C. Welsh

July 16, 2014

$Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial$

Presentation

Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial

Presenter: A. Shahzad

July 10, 2014

Advertisement

The Data Strongly Support Heparin!

The Data Strongly Support Bivalirudin!

The Data Strongly Support Heparin!

The Data Strongly Support Bivalirudin!

Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Role of New Oral Anticoagulants and New ADP Antagonists in ACS Patients

Antithrombin Therapy and GP IIb/IIIa Inhibitors in Patients with ACS and in Those Undergoing PCI

Optimal Duration of DAPT After Intracoronary Stenting: Current Status

Are GP IIb/IIIa Inhibitors Still Useful?

Aspirin Treatment and Outcomes After PCI

Bivalirudin vs Heparin in Patients Planned for PCI

Early High-Dose Rosuvastatin and Cardioprotection

Contemporary Patterns of Discharge Aspirin Dosing After Acute MI in the United States

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Issues with DAPT: An Expert Case-Based Discussion

Pharmacotherapy for Primary PCI - Late Breaking Trials: EUROMAX, HEAT-PPCI, BRIGHT, and BRAVE 4

Variability of Individual Platelet Reactivity Over Time in Patients Treated with Clopidogrel

STREAM Substudy: Outcomes of Pharmacoinvasive Strategy for Successful vs Failed Fibrinolysis and Primary PCI in AMI

Unfractionated Heparin vs Bivalirudin in Primary PCI: An Open-label, Single-Center, Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content